The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Abuse Deterrent Formulation Technologies Market Research Report 2025
Synopsis
Evaluate the general principles of oral solid opioid deterrence deterrence to ensure that there are certain identified anti-abuse measures under the possible routes of abuse to minimize the risk of drug abuse.
The global Abuse Deterrent Formulation Technologies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Abuse Deterrent Formulation Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Abuse Deterrent Formulation Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Abuse Deterrent Formulation Technologies in Tablet is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Abuse Deterrent Formulation Technologies include Acura Pharmaceuticals, Altus Formulation, BioDelivery Sciences International, Teva Pharmaceutical, Elysium Therapeutics, Grünenthal, Intellipharmaceutics, Purdue Pharma and TITAN Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Abuse Deterrent Formulation Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Abuse Deterrent Formulation Technologies.
Report Scope
The Abuse Deterrent Formulation Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Abuse Deterrent Formulation Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Abuse Deterrent Formulation Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acura Pharmaceuticals
Altus Formulation
BioDelivery Sciences International
Teva Pharmaceutical
Elysium Therapeutics
Grünenthal
Intellipharmaceutics
Purdue Pharma
TITAN Pharmaceuticals
Segment by Type
Antidepressants
CNS Stimulants
Others
Segment by Application
Tablet
Capsule
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Abuse Deterrent Formulation Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Evaluate the general principles of oral solid opioid deterrence deterrence to ensure that there are certain identified anti-abuse measures under the possible routes of abuse to minimize the risk of drug abuse.
The global Abuse Deterrent Formulation Technologies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Abuse Deterrent Formulation Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Abuse Deterrent Formulation Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Abuse Deterrent Formulation Technologies in Tablet is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Abuse Deterrent Formulation Technologies include Acura Pharmaceuticals, Altus Formulation, BioDelivery Sciences International, Teva Pharmaceutical, Elysium Therapeutics, Grünenthal, Intellipharmaceutics, Purdue Pharma and TITAN Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Abuse Deterrent Formulation Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Abuse Deterrent Formulation Technologies.
Report Scope
The Abuse Deterrent Formulation Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Abuse Deterrent Formulation Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Abuse Deterrent Formulation Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acura Pharmaceuticals
Altus Formulation
BioDelivery Sciences International
Teva Pharmaceutical
Elysium Therapeutics
Grünenthal
Intellipharmaceutics
Purdue Pharma
TITAN Pharmaceuticals
Segment by Type
Antidepressants
CNS Stimulants
Others
Segment by Application
Tablet
Capsule
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Abuse Deterrent Formulation Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Abuse Deterrent Formulation Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antidepressants
1.2.3 CNS Stimulants
1.2.4 Others
1.3 Market by Application
1.3.1 Global Abuse Deterrent Formulation Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Abuse Deterrent Formulation Technologies Market Perspective (2019-2030)
2.2 Abuse Deterrent Formulation Technologies Growth Trends by Region
2.2.1 Global Abuse Deterrent Formulation Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Abuse Deterrent Formulation Technologies Historic Market Size by Region (2019-2024)
2.2.3 Abuse Deterrent Formulation Technologies Forecasted Market Size by Region (2025-2030)
2.3 Abuse Deterrent Formulation Technologies Market Dynamics
2.3.1 Abuse Deterrent Formulation Technologies Industry Trends
2.3.2 Abuse Deterrent Formulation Technologies Market Drivers
2.3.3 Abuse Deterrent Formulation Technologies Market Challenges
2.3.4 Abuse Deterrent Formulation Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Abuse Deterrent Formulation Technologies Players by Revenue
3.1.1 Global Top Abuse Deterrent Formulation Technologies Players by Revenue (2019-2024)
3.1.2 Global Abuse Deterrent Formulation Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Abuse Deterrent Formulation Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Abuse Deterrent Formulation Technologies Revenue
3.4 Global Abuse Deterrent Formulation Technologies Market Concentration Ratio
3.4.1 Global Abuse Deterrent Formulation Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Abuse Deterrent Formulation Technologies Revenue in 2023
3.5 Abuse Deterrent Formulation Technologies Key Players Head office and Area Served
3.6 Key Players Abuse Deterrent Formulation Technologies Product Solution and Service
3.7 Date of Enter into Abuse Deterrent Formulation Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Abuse Deterrent Formulation Technologies Breakdown Data by Type
4.1 Global Abuse Deterrent Formulation Technologies Historic Market Size by Type (2019-2024)
4.2 Global Abuse Deterrent Formulation Technologies Forecasted Market Size by Type (2025-2030)
5 Abuse Deterrent Formulation Technologies Breakdown Data by Application
5.1 Global Abuse Deterrent Formulation Technologies Historic Market Size by Application (2019-2024)
5.2 Global Abuse Deterrent Formulation Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Abuse Deterrent Formulation Technologies Market Size (2019-2030)
6.2 North America Abuse Deterrent Formulation Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Abuse Deterrent Formulation Technologies Market Size by Country (2019-2024)
6.4 North America Abuse Deterrent Formulation Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Abuse Deterrent Formulation Technologies Market Size (2019-2030)
7.2 Europe Abuse Deterrent Formulation Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Abuse Deterrent Formulation Technologies Market Size by Country (2019-2024)
7.4 Europe Abuse Deterrent Formulation Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Abuse Deterrent Formulation Technologies Market Size (2019-2030)
8.2 Asia-Pacific Abuse Deterrent Formulation Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Abuse Deterrent Formulation Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Abuse Deterrent Formulation Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Abuse Deterrent Formulation Technologies Market Size (2019-2030)
9.2 Latin America Abuse Deterrent Formulation Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Abuse Deterrent Formulation Technologies Market Size by Country (2019-2024)
9.4 Latin America Abuse Deterrent Formulation Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Abuse Deterrent Formulation Technologies Market Size (2019-2030)
10.2 Middle East & Africa Abuse Deterrent Formulation Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Abuse Deterrent Formulation Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Abuse Deterrent Formulation Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acura Pharmaceuticals
11.1.1 Acura Pharmaceuticals Company Detail
11.1.2 Acura Pharmaceuticals Business Overview
11.1.3 Acura Pharmaceuticals Abuse Deterrent Formulation Technologies Introduction
11.1.4 Acura Pharmaceuticals Revenue in Abuse Deterrent Formulation Technologies Business (2019-2024)
11.1.5 Acura Pharmaceuticals Recent Development
11.2 Altus Formulation
11.2.1 Altus Formulation Company Detail
11.2.2 Altus Formulation Business Overview
11.2.3 Altus Formulation Abuse Deterrent Formulation Technologies Introduction
11.2.4 Altus Formulation Revenue in Abuse Deterrent Formulation Technologies Business (2019-2024)
11.2.5 Altus Formulation Recent Development
11.3 BioDelivery Sciences International
11.3.1 BioDelivery Sciences International Company Detail
11.3.2 BioDelivery Sciences International Business Overview
11.3.3 BioDelivery Sciences International Abuse Deterrent Formulation Technologies Introduction
11.3.4 BioDelivery Sciences International Revenue in Abuse Deterrent Formulation Technologies Business (2019-2024)
11.3.5 BioDelivery Sciences International Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Detail
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Abuse Deterrent Formulation Technologies Introduction
11.4.4 Teva Pharmaceutical Revenue in Abuse Deterrent Formulation Technologies Business (2019-2024)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Elysium Therapeutics
11.5.1 Elysium Therapeutics Company Detail
11.5.2 Elysium Therapeutics Business Overview
11.5.3 Elysium Therapeutics Abuse Deterrent Formulation Technologies Introduction
11.5.4 Elysium Therapeutics Revenue in Abuse Deterrent Formulation Technologies Business (2019-2024)
11.5.5 Elysium Therapeutics Recent Development
11.6 Grünenthal
11.6.1 Grünenthal Company Detail
11.6.2 Grünenthal Business Overview
11.6.3 Grünenthal Abuse Deterrent Formulation Technologies Introduction
11.6.4 Grünenthal Revenue in Abuse Deterrent Formulation Technologies Business (2019-2024)
11.6.5 Grünenthal Recent Development
11.7 Intellipharmaceutics
11.7.1 Intellipharmaceutics Company Detail
11.7.2 Intellipharmaceutics Business Overview
11.7.3 Intellipharmaceutics Abuse Deterrent Formulation Technologies Introduction
11.7.4 Intellipharmaceutics Revenue in Abuse Deterrent Formulation Technologies Business (2019-2024)
11.7.5 Intellipharmaceutics Recent Development
11.8 Purdue Pharma
11.8.1 Purdue Pharma Company Detail
11.8.2 Purdue Pharma Business Overview
11.8.3 Purdue Pharma Abuse Deterrent Formulation Technologies Introduction
11.8.4 Purdue Pharma Revenue in Abuse Deterrent Formulation Technologies Business (2019-2024)
11.8.5 Purdue Pharma Recent Development
11.9 TITAN Pharmaceuticals
11.9.1 TITAN Pharmaceuticals Company Detail
11.9.2 TITAN Pharmaceuticals Business Overview
11.9.3 TITAN Pharmaceuticals Abuse Deterrent Formulation Technologies Introduction
11.9.4 TITAN Pharmaceuticals Revenue in Abuse Deterrent Formulation Technologies Business (2019-2024)
11.9.5 TITAN Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
